Literature DB >> 36071498

VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells.

Wilson de Melo Cruvinel1, Luis Eduardo Coelho Andrade2, Alessandra Dellavance3,4, Antônio Carlos Ximenes5, Carlos David Araújo Bichara6, Cristóvão Luis Pitangueira Mangueira7, Eloísa Bonfá8, Fabiano de Almeida Brito9,10, Henrique Ataíde Mariz11, Lisiane Maria Enriconi Dos Anjos12, Sandra Gofinet Pasoto13, Valeria Valim14, Wilton Ferreira Silva Dos Santos15, Clayson Moura Gomes16, Roberpaulo Anacleto Neves16, Paulo Luiz Carvalho Francescantonio16.   

Abstract

BACKGROUND: The VI Brazilian Consensus on Autoantibodies against HEp-2 cells for determination of autoantibodies against cellular constituents on HEp-2 cells was held on September, 2019, in Fortaleza (CE, Brazil). The guidelines in this edition were formulated by the group of Brazilian experts discussing the classification of complex patterns, the classification of the nuclear discrete dots (few and multiple), the identification of the discrete fine speckled pattern (AC-4a) and improvements on the ANA report. MAINBODY: Sixteen Brazilian researchers and experts from universities and clinical laboratories representing the various geographical regions of Brazil participated in the meeting. Four main topics were discussed: (1) How to classify patterns with fluorescence in more than one cell compartment considering three relevant categoris: composite patterns, mixed patterns and multiple patterns; (2) The splitting of the discrete nuclear dots pattern into the multiple discrete nuclear dots (AC-6) and few discrete nuclear dots (AC-7) patterns, respectively; (3) Inclusion of a novel nuclear pattern characterized by discrete fine speckled pattern highly associated with antibodies to SS-A/Ro60, classified as AC-4a. In addition, adjustments on the Brazilian Consensus nomenclature were implemented aiming to harmonize the designation of some patterns with the International Consensus on ANA Patterns (ICAP). Furthermore, the designations of the PCNA-like pattern (AC-13), CENP-F-like pattern (AC-14) and Topo I-like pattern (AC-29) were adjusted in accordance to ICAP. Finally, there was a recommendation for adjustment in the test report in order to address the status of nuclear envelope staining. For all topics, the aim was to establish specific guidelines for laboratories and clinicians. All recommendations were based on consensus among participants. All recommendations from the V Consensus were maintained and there was relevant progress in the BCA/HEp-2 guidelines and further harmonization with ICAP.
CONCLUSION: The VI BCA/HEp-2 edition was successful in establishing important recommendations regarding the classification of complex patterns, in supporting the identification of a novel pattern within the AC-4 group and in the harmonization process with the ICAP terminology.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36071498     DOI: 10.1186/s42358-022-00266-z

Source DB:  PubMed          Journal:  Adv Rheumatol        ISSN: 2523-3106


  22 in total

1.  V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells.

Authors:  Wilson de Melo Cruvinel; Luis Eduardo Coelho Andrade; Carlos Alberto von Mühlen; Alessandra Dellavance; Antônio Carlos Ximenes; Carlos David Bichara; Cleonice Bueno; Cristóvão Luis Pitangueira Mangueira; Eloísa Bonfá; Fabiano de Almeida Brito; Fernanda Bull Flumian; Glaucielen Gomes da Silva; Jozelia Rêgo; Lisiane Maria Ericoni Dos Anjos; Natasha Slhessarenko; Sandra Gofinet Pasoto; Suzane Pretti Figueiredo Neves; Valéria Valim; Wilton Silva Dos Santos; Paulo Luiz Carvalho Francescantonio
Journal:  Adv Rheumatol       Date:  2019-07-03

2.  Analysis of a multiple nuclear dots pattern in a large cohort of dermatological patients.

Authors:  Emanuele Cozzani; Massimo Drosera; Silvia Riva; Aurora Parodi
Journal:  Clin Lab       Date:  2012       Impact factor: 1.138

3.  IV Brazilian guidelines for autoantibodies on HEp-2 cells.

Authors:  Paulo Luiz Carvalho Francescantonio; Wilson de Melo Cruvinel; Alessandra Dellavance; Luis Eduardo Coelho Andrade; Ben Hur Taliberti; Carlos Alberto von Mühlen; Carlos David Araújo Bichara; Cleonice Bueno; Cristóvão Luis Pitangueira Mangueira; Darlene Gonçalves Carvalho; Eloísa S D de O Bonfá; Fabiano de Almeida Brito; Flávia Ikeda e Araújo; Jozelia Rêgo; Kaline Medeiros Costa Pereira; Lisiane Maria Enriconi dos Anjos; Maria de Fatima Bissoli; Mittermayer Barreto Santiago; Natalya Zaidan Maluf; Rossana Rassi Alvarenga; Suzane Pretti Figueiredo Neves; Valeria Valim; Wilton Silva dos Santos
Journal:  Rev Bras Reumatol       Date:  2014 Jan-Feb

4.  International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I.

Authors:  Luis E C Andrade; Werner Klotz; Manfred Herold; Karsten Conrad; Johan Rönnelid; Marvin J Fritzler; Carlos A von Mühlen; Minoru Satoh; Jan Damoiseaux; Wilson de Melo Cruvinel; Edward K L Chan
Journal:  Clin Chem Lab Med       Date:  2018-09-25       Impact factor: 3.694

5.  Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100).

Authors:  C Szostecki; H Krippner; E Penner; F A Bautz
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

6.  Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.

Authors:  D Züchner; T Sternsdorf; C Szostecki; E J Heathcote; K Cauch-Dudek; H Will
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

7.  Nuclear dot antigens may specify transcriptional domains in the nucleus.

Authors:  K Xie; E J Lambie; M Snyder
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

8.  Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis.

Authors:  T Sternsdorf; H H Guldner; C Szostecki; T Grötzinger; H Will
Journal:  Scand J Immunol       Date:  1995-08       Impact factor: 3.487

9.  Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies.

Authors:  M Fusconi; F Cassani; M Govoni; A Caselli; F Farabegoli; M Lenzi; G Ballardini; D Zauli; F B Bianchi
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

Review 10.  Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Front Immunol       Date:  2015-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.